Nkarta (NKTX) Projected to Release Earnings on Tuesday

Nkarta (NASDAQ:NKTX) is anticipated to issue its Q2 2026 results before the market opens on Tuesday, August 11th. Analysts expect Nkarta to announce earnings of ($0.39) per share for the quarter. Interested persons may visit the the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Tuesday, August 11, 2026 at 4:00 PM ET.

Nkarta (NASDAQ:NKTX) last posted its quarterly earnings results on Tuesday, May 12th. The company reported ($0.37) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.39) by $0.02. On average, analysts expect Nkarta to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Nkarta Trading Up 3.0%

NASDAQ NKTX traded up $0.07 on Tuesday, hitting $2.21. 148,492 shares of the company’s stock traded hands, compared to its average volume of 762,760. The firm’s 50-day moving average price is $2.76 and its two-hundred day moving average price is $2.57. The firm has a market capitalization of $158.46 million, a PE ratio of -1.65 and a beta of 0.93. Nkarta has a 1-year low of $1.70 and a 1-year high of $3.72.

Institutional Investors Weigh In On Nkarta

Several hedge funds have recently modified their holdings of NKTX. GSK plc acquired a new stake in shares of Nkarta during the 4th quarter valued at about $5,829,000. Jane Street Group LLC increased its stake in shares of Nkarta by 118.7% in the 1st quarter. Jane Street Group LLC now owns 134,286 shares of the company’s stock valued at $247,000 after purchasing an additional 852,559 shares in the last quarter. Millennium Management LLC acquired a new position in Nkarta in the 3rd quarter worth about $1,549,000. Renaissance Technologies LLC raised its holdings in Nkarta by 48.6% in the 4th quarter. Renaissance Technologies LLC now owns 1,702,022 shares of the company’s stock worth $3,149,000 after purchasing an additional 556,945 shares during the period. Finally, AQR Capital Management LLC boosted its position in Nkarta by 300.5% during the first quarter. AQR Capital Management LLC now owns 672,078 shares of the company’s stock worth $1,237,000 after purchasing an additional 504,272 shares in the last quarter. 80.54% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

NKTX has been the subject of several recent research reports. Evercore set a $9.00 target price on shares of Nkarta in a report on Monday, May 18th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Nkarta in a research report on Wednesday, June 24th. Needham & Company LLC reiterated a “buy” rating and set a $11.00 price objective on shares of Nkarta in a research note on Wednesday, May 13th. TD Cowen started coverage on Nkarta in a research note on Tuesday, June 23rd. They set a “buy” rating for the company. Finally, Wall Street Zen raised Nkarta from a “strong sell” rating to a “sell” rating in a report on Sunday. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Nkarta has a consensus rating of “Moderate Buy” and a consensus price target of $10.75.

Nkarta Company Profile

Nkarta, Inc is a clinical-stage biotechnology company specializing in the development of off-the-shelf natural killer (NK) cell therapies for the treatment of cancer. Leveraging proprietary activation and expansion technologies, Nkarta aims to harness the innate tumor-killing properties of NK cells while incorporating targeted immuno-engineering approaches to enhance safety, potency and persistence in patients. The company’s platform supports both allogeneic cell manufacturing and genetic modifications to generate chimeric antigen receptor-expressing NK cell candidates designed to address a range of hematologic and solid tumors.

Nkarta’s lead program, NKX019, is an anti-CD19 CAR-NK cell therapy in early-phase clinical trials for relapsed or refractory B-cell malignancies.